Spectrum Pharmaceuticals (SPPI) PT Lowered to $4 at JMP Securities, After Receiving FDA CRL
Tweet
Share
E-mail
Get Alerts SPPI Hot Sheet
Price: $1.03 --0%
Rating Summary:
3 Buy, 6 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 10
Rating Summary:
3 Buy, 6 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 10
Join SI Premium – FREE
JMP Securities analyst Reni J. Benjamin lowered the price target on Spectrum Pharmaceuticals (NASDAQ: SPPI) to $4.00 (from $12.00) while maintaining a Market Outperform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Deere (DE) PT Lowered to $570 at JPMorgan Ahead of Earnings
- Target (TGT) PT Raised to $146 at Piper Sandler
- Evercore ISI Starts Alvotech SA (ALVO) at Outperform
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
JMP Securities, FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
